Filing Details
- Accession Number:
- 0000899243-19-007113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-11 19:18:12
- Reporting Period:
- 2019-03-07
- Accepted Time:
- 2019-03-11 19:18:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1631574 | Wave Life Sciences Ltd. | WVE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1679039 | A. Michael Panzara | C/O Wave Life Sciences Ltd., 733 Concord Ave. Cambridge MA 02138 | Franchise Lead, Neurology | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2019-03-07 | 15,000 | $0.00 | 52,388 | No | 4 | A | Direct | |
Ordinary Shares | Disposition | 2019-03-11 | 7,000 | $48.00 | 45,388 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2020 through February 15, 2023.
- Consists of sale of RSUs effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018.